抗新型冠状病毒候选药物法维拉韦首批国家对照品的研制
熊婧, 严菁, 刘毅, 刘阳, 何兰
Development of the first national reference substance of favipiravir as a candidate drug against COVID-19
XIONG Jing, YAN Jing, LIU Yi, LIU Yang, HE Lan
中国药物警戒
.
2022, (1): 52
-56
.
DOI: 10.19803/j.1672-8629.2022.01.11
